AIM
AGL icon

Acropolis Investment Management’s Agilon Health AGL Stock Holding History

Acropolis Investment Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,400
Closed -$24.1K – 385
2025
Q4 		$24.1K Buy
1,400
+640
+84% +$12.4K ﹤0.01% 295
2025
Q3 		$43.7K Hold
760
– – ﹤0.01% 265
2025
Q2 		$43.7K Buy
+760
New +$61K ﹤0.01% 245

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Acropolis Investment Management's AGL Position: Q1 2026 in Review

Acropolis Investment Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 1,400 shares — an estimated $24.1K sold.

Acropolis Investment Management first reported a position in AGL in Q2 2025 and held it in 3 quarters. The position peaked at $43.7K in Q3 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Acropolis Investment Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Acropolis Investment Management sold 1,400 Agilon Health shares in Q1 2026, an estimated $24.1K.
  • Acropolis Investment Management first reported a position in Agilon Health in Q2 2025 and held it in 3 quarters.
  • Acropolis Investment Management's Agilon Health position peaked at $43.7K in Q3 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Acropolis Investment Management's 13F filing for Q1 2026, filed 9 Apr 2026.